MRD in Focus Part 1: The Current State of Affairs

A 3-Part Webinar Series on the Current and Future Role of Minimal Residual Disease in Oncology 

Minimal Residual Disease (MRD) is emerging as one of the most promising applications of precision oncology. As technologies advance and clinical evidence continues to grow, MRD testing has the potential to transform how cancer is monitored, how treatment decisions are made, and ultimately how patient outcomes are improved. 

Join leading experts for a three-part webinar series exploring the current state of MRD, the evolving evidence landscape, and future opportunities for clinical implementation. 

Whether you are a molecular pathologist, oncologist, laboratory director, researcher, or precision medicine professional, this series will provide valuable insights into one of the most rapidly advancing fields in cancer diagnostics. 

What You Will Learn 

• The current status of MRD testing across different tumor types 
• Clinical applications and emerging use cases 
• Technological approaches and implementation considerations 
• Challenges and opportunities for adoption in routine practice 
• Future directions and the role of MRD in precision oncology 

Webinar Series Agenda 

Part 1: The Current State of Affairs 

17 November | 16:00-17:00 CET 

Gain an overview of today's MRD landscape, including the latest scientific developments, current clinical evidence, and key considerations for integrating MRD into oncology workflows. 

Speaker:
Prof. Dr. med. Albrecht Stenzinger 
Institute of Pathology, Heidelberg University Hospital 

Who Should Attend? 

This webinar series is designed for: 

• Molecular Pathologists 
• Medical Oncologists 
• Clinical Researchers 
• Laboratory Directors and Managers 
• Precision Medicine Professionals 
• Translational Scientists 

Why Attend? 

MRD testing is rapidly becoming a key area of interest across oncology. Understanding the clinical evidence, technological innovations, and implementation considerations is essential for healthcare professionals seeking to stay at the forefront of precision cancer care. 

Join this expert-led series to gain practical insights, hear from leading voices in the field, and stay informed about one of the most exciting developments in oncology today. 

Register now to secure your place.